ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,672.60
0.57%
S&P ASX All Technology
3,019.10
0.09%
Brent Oil
83.065
-0.07%
US Dollar vs AUD
1.51208
-0.05%
Bitcoin
64,118.29
0.19%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. ImmunityBio Inc (IBRX)

  7. ImmunityBio Inc (IBRX) News

IBRX ImmunityBio Inc

9.07
0.10 (1.11%)
04 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
ImmunityBio Inc IBRX NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
0.10 1.11% 9.07 14:00:09
Open Price Low Price High Price Close Price Previous Close
9.48 8.645 10.01 9.15 8.97
more quote information »

Recent News

Date Time Source Heading
03/5/202406:04BWImmunityBio, Serum Institute of India Agree on an Exclusive..
30/4/202422:00BWImmunityBio Executive Chairman Dr. Patrick Soon-Shiong to..
25/4/202414:03BWImmunityBio Announces Positive Overall Survival Results of..
23/4/202411:56BWImmunityBio Announces FDA Approval of ANKTIVA®,..
07/3/202401:00BWNIAID-Sponsored Study Shows N-803 Combined with Neutralizing..
06/3/202401:00BWN-803 Combined with Natural Killer Cells Showed Potential to..
27/2/202408:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202408:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202408:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/2/202413:28EDGAR2Form 8-K - Current report
22/2/202401:00BWImmunityBio Announces Full Accrual of First Two Phases of..
07/2/202413:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202401:00BWImmunityBio Quality-of-Life Study in BCG-Unresponsive..
03/2/202411:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/2/202411:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202413:59EDGAR2Form SC 13D/A - General statement of acquisition of..
04/1/202413:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202413:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202422:08EDGAR2Form 8-K - Current report
02/1/202422:00BWImmunityBio Announces $320 Million Investment by Oberland..
17/11/202301:00BWImmunityBio to Participate in 35th Annual Piper Sandler..
09/11/202313:28EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/11/202301:00BWFirst Data for ImmunityBio’s Memory Cytokine-Enriched NK..
27/10/202303:03DJNImmunityBio Shares Rally as FDA Accepts N-803 Resubmission
27/10/202300:00BWFDA Accepts ImmunityBio’s BLA Resubmission as Complete and..
24/10/202302:00DJNImmunityBio Shares 11% Higher on License Application..
24/10/202300:00BWImmunityBio Announces Biological License Application..
28/9/202320:06EDGAR2Form DEF 14C - Other definitive information statements
23/9/202305:06EDGAR2Form D - Notice of Exempt Offering of Securities
22/9/202306:25EDGAR2Form SC 13D/A - General statement of acquisition of..
11/9/202320:25EDGAR2Form 8-K - Current report
11/9/202320:00BWImmunityBio Announces $470 Million Equity and Debt Financing..
07/9/202309:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/9/202309:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/9/202322:30EDGAR2Form 8-K - Current report
29/8/202319:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
29/8/202311:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/8/202310:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/8/202319:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
16/8/202319:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
16/8/202306:15EDGAR2Form 8-K - Current report
11/8/202319:45PRNUSIBRX SHAREHOLDER ALERT: Jakubowitz Law Reminds ImmunityBio..
09/8/202319:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
09/8/202306:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
04/8/202319:45PRNUSIBRX SHAREHOLDER ALERT: Jakubowitz Law Reminds ImmunityBio..
03/8/202323:00BWImmunityBio Names Enrique Diloné as Chief Technology Officer
02/8/202319:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
28/7/202319:45PRNUSIBRX SHAREHOLDER ALERT: Jakubowitz Law Reminds ImmunityBio..
26/7/202319:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
26/7/202307:02EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]

Your Recent History

NASDAQ
IBRX
ImmunityBio
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved